Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Cardiff Oncology (CRDF) Receivables - Net (2016 - 2025)

Cardiff Oncology's Receivables - Net history spans 15 years, with the latest figure at $182000.0 for Q4 2025.

  • For Q4 2025, Receivables - Net fell 76.46% year-over-year to $182000.0; the TTM value through Dec 2025 reached $182000.0, down 76.46%, while the annual FY2025 figure was $182000.0, 76.46% down from the prior year.
  • Receivables - Net for Q4 2025 was $182000.0 at Cardiff Oncology, down from $254000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $773000.0 in Q4 2024 and bottomed at $161000.0 in Q2 2023.
  • The 5-year median for Receivables - Net is $426000.0 (2022), against an average of $441200.0.
  • The largest annual shift saw Receivables - Net soared 212.12% in 2024 before it crashed 76.46% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $535000.0 in 2021, then soared by 44.11% to $771000.0 in 2022, then tumbled by 62.65% to $288000.0 in 2023, then soared by 168.4% to $773000.0 in 2024, then plummeted by 76.46% to $182000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Receivables - Net are $182000.0 (Q4 2025), $254000.0 (Q3 2025), and $526000.0 (Q2 2025).